Enanta Pharmaceuticals Inc (ENTA)
9.30
+0.22
(+2.42%)
USD |
NASDAQ |
Nov 21, 16:00
9.30
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap: 197.05M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 192.39M |
| November 19, 2024 | 199.60M |
| November 18, 2024 | 202.77M |
| November 15, 2024 | 201.93M |
| November 14, 2024 | 214.64M |
| November 13, 2024 | 221.00M |
| November 12, 2024 | 225.87M |
| November 11, 2024 | 230.32M |
| November 08, 2024 | 234.56M |
| November 07, 2024 | 240.49M |
| November 06, 2024 | 244.09M |
| November 05, 2024 | 238.58M |
| November 04, 2024 | 235.41M |
| November 01, 2024 | 232.02M |
| October 31, 2024 | 238.27M |
| October 30, 2024 | 243.46M |
| October 29, 2024 | 243.67M |
| October 28, 2024 | 245.36M |
| October 25, 2024 | 247.48M |
| October 24, 2024 | 257.44M |
| October 23, 2024 | 270.15M |
| October 22, 2024 | 275.45M |
| October 21, 2024 | 267.82M |
| October 18, 2024 | 267.61M |
| October 17, 2024 | 260.20M |
| Date | Value |
|---|---|
| October 16, 2024 | 256.38M |
| October 15, 2024 | 247.27M |
| October 14, 2024 | 239.64M |
| October 11, 2024 | 233.92M |
| October 10, 2024 | 225.23M |
| October 09, 2024 | 226.93M |
| October 08, 2024 | 233.07M |
| October 07, 2024 | 244.73M |
| October 04, 2024 | 241.76M |
| October 03, 2024 | 237.10M |
| October 02, 2024 | 238.37M |
| October 01, 2024 | 231.80M |
| September 30, 2024 | 219.51M |
| September 27, 2024 | 212.95M |
| September 26, 2024 | 221.84M |
| September 25, 2024 | 226.08M |
| September 24, 2024 | 230.96M |
| September 23, 2024 | 233.07M |
| September 20, 2024 | 239.01M |
| September 19, 2024 | 239.43M |
| September 18, 2024 | 241.34M |
| September 17, 2024 | 246.85M |
| September 16, 2024 | 250.24M |
| September 13, 2024 | 263.37M |
| September 12, 2024 | 258.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.26M
Minimum
Nov 13 2023
1.979B
Maximum
Nov 05 2021
840.64M
Average
948.01M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
| Oragenics Inc | 3.301M |
Market Cap Related Metrics
| PS Ratio | 2.730 |
| Price to Book Value | 1.323 |
| Price | 9.30 |
| Earnings Yield | -58.60% |